| Mon, 30 Nov 2020 13:39:42: | Cambridge, Lund University spinout Wren pens Eisai neuro research pact
|
| Mon, 30 Nov 2020 12:26:43: | Moderna sketches out 94.1% efficacy for COVID-19 vax based on more cases, with EUA plotted for today
|
| Mon, 30 Nov 2020 12:22:24: | Enhancing cancer-fighting T cells by manipulating their microenvironment
|
| Mon, 30 Nov 2020 10:33:51: | Biogen bets $1.5B on Sage's once-failed depression drug
|
| Mon, 30 Nov 2020 09:48:32: | AstraZeneca nears temporary OK for COVID-19 vaccine, plots extra trial
|
| Wed, 25 Nov 2020 13:32:39: | Fancy a Black Friday R&D deal? Astellas has you covered
|
| Wed, 25 Nov 2020 12:43:04: | Cancer-killing virus escapes immune destruction and fights metastatic lung tumors in mice
|
| Wed, 25 Nov 2020 11:47:09: | BioNTech, Fosun start COVID-19 vaccine trial to support Chinese approval
|
| Wed, 25 Nov 2020 11:01:15: | Urovant's vibegron flunks irritable bowel syndrome phase 2
|
| Wed, 25 Nov 2020 09:01:06: | Galapagos sells off Fidelta as CRO activities 'no longer fit with its strategy'
|
| Tue, 24 Nov 2020 14:48:17: | Anti-aging biotech Elevian raises $15M as it looks to the clinic
|
| Tue, 24 Nov 2020 13:37:22: | Hoping for an endgame, GSK kick-starts phase 3 RSV vaccine trial in pregnant women
|
| Tue, 24 Nov 2020 13:11:43: | AstraZeneca probes 'mistake' behind 90% COVID-19 vaccine efficacy
|
| Tue, 24 Nov 2020 11:56:56: | Twist Bioscience's COVID-19 'nanobodies,' inspired by llamas, show promise in hamsters
|
| Tue, 24 Nov 2020 11:37:22: | Immunocore's TCR bispecific improves survival in solid tumor phase 3
|
| Mon, 23 Nov 2020 13:20:06: | Merck inks $425M OncoImmune buyout to bag COVID-19 drug
|
| Mon, 23 Nov 2020 13:15:38: | Black Diamond's EFGR-targeted glioblastoma drug candidate slows tumor growth in mice
|
| Mon, 23 Nov 2020 10:58:51: | AstraZeneca's COVID-19 vaccine 70% effective, shares fall
|
| Mon, 23 Nov 2020 08:55:48: | Belgium biotech argenx nabs Bayer speedy review voucher for a cool $98M
|
| Fri, 20 Nov 2020 13:27:03: | Adagio's COVID-19 antibody protects mice and zaps related viruses in lab tests
|
| Fri, 20 Nov 2020 13:19:15: | ADC gets priority review for anti-CD19 blood cancer drug
|
| Fri, 20 Nov 2020 11:47:11: | Novartis licenses phase 3 COVID-19 cell therapy from Mesoblast
|
| Fri, 20 Nov 2020 08:56:54: | Ahead of possible Japanese approval, Metavant backs away from Poxel-partnered imeglimin
|
| Thu, 19 Nov 2020 21:39:11: | Chutes & Ladders—Longtime AbbVie commercial chief Alban announces retirement
|
| Thu, 19 Nov 2020 15:38:25: | Gene therapy hemophilia B 'cure' approach heats up as uniQure/CSL, rivaling Pfizer, shows promise
|
